Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020

SELL
$87.74 - $152.74 $294,455 - $512,595
-3,356 Closed
0 $0
Q4 2019

Jan 13, 2020

BUY
$117.65 - $153.73 $40,942 - $53,498
348 Added 11.57%
3,356 $501,000
Q3 2019

Oct 03, 2019

SELL
$125.18 - $143.24 $154,221 - $176,471
-1,232 Reduced 29.06%
3,008 $386,000
Q2 2019

Jul 15, 2019

BUY
$125.55 - $144.48 $434,151 - $499,611
3,458 Added 442.2%
4,240 $604,000
Q1 2019

Apr 02, 2019

BUY
$121.81 - $142.95 $56,276 - $66,042
462 Added 144.38%
782 $112,000
Q4 2018

Jan 11, 2019

BUY
$115.94 - $166.74 $11,014 - $15,840
95 Added 42.22%
320 $39,000
Q3 2018

Oct 16, 2018

BUY
$161.01 - $180.57 $36,227 - $40,628
225 New
225 $38,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.